Zydus Wellness board meeting scheduled for May 18, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Board will consider recommending final dividend for FY2026, subject to shareholder approval.
Trading window closure for insiders effective until May 20, 2026, reopening on May 21, 2026 in compliance with SEBI insider trading regulations.
Regulatory disclosure made under SEBI LODR Regulation 29(1) for mandatory board meeting intimation.